Novartis Can Go Ahead with Purchase of Lek, Drug-Maker's Supervisors Decide
Ljubljana, 28 August - The supervisory board of a Ljubljana-based drug-maker said Wednesday that a strategic partnership with Novartis, a Swiss multinational, would be in line with the company's strategic plans. With this decision, Lek supervisors confirmed that the deal is "a friendly takeover".
The rest of this news item is available to subscribers.
The news item consists of 765 characters (without spaces) or 151 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.